Levocetirizine Dihydrochloride Ipca

Levocetirizine Dihydrochloride, the active ingredient in Levocetirizine Dihydrochloride Ipca, is a second‑generation H1 antihistamine presented as an oral dosage form for systemic use. It is indicated for the relief of allergic symptoms such as sneezing, itching and rhinorrhea in patients with allergic rhinitis or chronic idiopathic urticaria. GNH USA supplies Levocetirizine Dihydrochloride Ipca as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levocetirizine Dihydrochloride acts on histamine‑mediated allergic pathways and is used for the following conditions: - Allergic rhinitis (seasonal): reduces nasal congestion, sneezing and watery discharge. - Allergic rhinitis (perennial): alleviates continuous nasal itching and discharge. - Chronic idiopathic urticaria: diminishes hives and associated itching, improving quality of life.

Levocetirizine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Drowsiness: mild sleepiness, especially at treatment initiation. - Dry mouth: reduced salivary flow causing throat discomfort. - Headache: transient cranial pain. - Nausea: mild gastrointestinal upset.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips or tongue requiring urgent care. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Anaphylaxis: rapid onset of systemic allergic response. - Tachycardia: abnormal increase in heart rate. - Hepatic dysfunction: abnormal liver enzyme elevations.

Before initiating therapy, consider the following precautions: - Assess renal function: dose adjustment may be needed in severe impairment. - Avoid use in known hypersensitivity: discontinue if allergic reaction occurs. - Caution in hepatic disease: monitor liver function tests periodically. - Monitor for sedation: especially when combined with other CNS depressants. - Pregnancy and lactation: consult a healthcare professional before use. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Levocetirizine may interact with several medicines; review patient medication lists carefully.

Major Interactions (Avoid): - Alcohol: can potentiate drowsiness and impair coordination. - CNS depressants (e.g., benzodiazepines): additive sedation risk.

Moderate Interactions (Monitor Closely): - Ritonavir: may increase levocetirizine plasma concentrations. - Theophylline: levocetirizine may reduce its clearance, requiring dose review. - Antifungal azoles (e.g., ketoconazole): can raise levocetirizine exposure, warranting monitoring.